This is a preview of subscription content, log in via an institution to check access.
Reference
Mahumud RA, et al. Cost-effectiveness Evaluations of the 9-Valent Human Papillomavirus (HPV) Vaccine: Evidence From a Systematic Review. PLOS One : 2 Jun 2020. Available from: URL: http://dx.doi.org/10.1371/journal.pone.0233499
Rights and permissions
About this article
Cite this article
Cost effectiveness of 9-valent HPV vaccine for cervical cancer prevention. PharmacoEcon Outcomes News 856, 10 (2020). https://doi.org/10.1007/s40274-020-6910-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6910-6